Matches in SemOpenAlex for { <https://semopenalex.org/work/W4235812858> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- W4235812858 endingPage "35" @default.
- W4235812858 startingPage "32" @default.
- W4235812858 abstract "The Eczema of the external auditory canal (EAC) is a challenge for the otolaryngologist and it’s a pathology that can annoy the patients and, in the most extreme cases, compromise their quality of life. Hence patients with eczema of EAC are exposed to a greater number of bacterial (acute bacterial otitis externa) or fungal (otomycosis) infections. The therapies proposed as of now for chronic eczematous external otitis (more than 3 months) are empirical. The most widely used drugs in this condition are topical corticosteroids which unfortunately can lead to dehydration of the skin, hypotropism with a reduction in their effectiveness over time Ozoile® (Stable Ozonides with Vitamin E acetate) acts as a biological inducer, regulates the main metabolic pathways, stimulates the endogenous defense system and through the regulation of gene transcription promotes tissue regeneration and damage-injury repair. This biological inducer has anti-inflammatory, anti-itching and anti-microbial action. Based on these results, the author used Ozoile® for the treatment of chronic eczematous external otitis (symptoms lasting more than three months). Sixty patients suffering from chronic eczematous otitis externa (CEOE) were recruited and given 1 month of treatment with 5 drops per ear in the morning and in the evening. Through a visual analogue scale (minimum score 0 and maximum 10 depending on the severity of the symptoms) the parameters itching, secretions, flaking and complications were evaluated at the beginning of the treatment (time 0) and at one month (time 1). After the treatment the results were as follow: 62.5% itching reduction, desquamation reduction by 72%, reduction of secretions by 80%. Total absence of side effects. We can conclude that Ozoile® (Stable Ozonides with Vitamin E acetate) has an excellent outcome in EAC eczema even for prolonged periods and is a manageable and complication-free biological inducer." @default.
- W4235812858 created "2022-05-12" @default.
- W4235812858 creator A5033240987 @default.
- W4235812858 date "2020-01-01" @default.
- W4235812858 modified "2023-10-18" @default.
- W4235812858 title "New therapeutic approach with ozoile® to the EAC eczema, a chronic and annoying pathology" @default.
- W4235812858 doi "https://doi.org/10.15406/joentr.2020.12.00452" @default.
- W4235812858 hasPublicationYear "2020" @default.
- W4235812858 type Work @default.
- W4235812858 citedByCount "0" @default.
- W4235812858 crossrefType "journal-article" @default.
- W4235812858 hasAuthorship W4235812858A5033240987 @default.
- W4235812858 hasBestOaLocation W42358128581 @default.
- W4235812858 hasConcept C108516343 @default.
- W4235812858 hasConcept C121332964 @default.
- W4235812858 hasConcept C1276947 @default.
- W4235812858 hasConcept C141071460 @default.
- W4235812858 hasConcept C142724271 @default.
- W4235812858 hasConcept C16005928 @default.
- W4235812858 hasConcept C2776439223 @default.
- W4235812858 hasConcept C2776476923 @default.
- W4235812858 hasConcept C2777640900 @default.
- W4235812858 hasConcept C2779923671 @default.
- W4235812858 hasConcept C2909951594 @default.
- W4235812858 hasConcept C71924100 @default.
- W4235812858 hasConceptScore W4235812858C108516343 @default.
- W4235812858 hasConceptScore W4235812858C121332964 @default.
- W4235812858 hasConceptScore W4235812858C1276947 @default.
- W4235812858 hasConceptScore W4235812858C141071460 @default.
- W4235812858 hasConceptScore W4235812858C142724271 @default.
- W4235812858 hasConceptScore W4235812858C16005928 @default.
- W4235812858 hasConceptScore W4235812858C2776439223 @default.
- W4235812858 hasConceptScore W4235812858C2776476923 @default.
- W4235812858 hasConceptScore W4235812858C2777640900 @default.
- W4235812858 hasConceptScore W4235812858C2779923671 @default.
- W4235812858 hasConceptScore W4235812858C2909951594 @default.
- W4235812858 hasConceptScore W4235812858C71924100 @default.
- W4235812858 hasIssue "1" @default.
- W4235812858 hasLocation W42358128581 @default.
- W4235812858 hasOpenAccess W4235812858 @default.
- W4235812858 hasPrimaryLocation W42358128581 @default.
- W4235812858 hasRelatedWork W2048484783 @default.
- W4235812858 hasRelatedWork W2094804737 @default.
- W4235812858 hasRelatedWork W2468113961 @default.
- W4235812858 hasRelatedWork W2915270115 @default.
- W4235812858 hasRelatedWork W2946742867 @default.
- W4235812858 hasRelatedWork W2973506068 @default.
- W4235812858 hasRelatedWork W3007259183 @default.
- W4235812858 hasRelatedWork W4247142507 @default.
- W4235812858 hasRelatedWork W4319078113 @default.
- W4235812858 hasRelatedWork W4322774817 @default.
- W4235812858 hasVolume "12" @default.
- W4235812858 isParatext "false" @default.
- W4235812858 isRetracted "false" @default.
- W4235812858 workType "article" @default.